Antigenic characterization of an abnormal isoform of prion protein using a new diverse panel of monoclonal antibodies

Virology

Volumn 320, Issue 1, 2004, Pages 40-51

  Kim, Chan Lan ^a   Umetani, Atsushi ^b   Matsui, Toshio ^b   Ishiguro, Naotaka ^a   Shinagawa, Morikazu ^a,d   Horiuchi, Motohiro ^a,c  

^a OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

^b FUJIREBIO INC   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

^d NATIONAL INSTITUTE OF ANIMAL HEALTH   (Japan)

Author keywords

BSE; Epitope mapping; Monoclonal antibody; Prion; Scrapie

Indexed keywords

EPITOPE; MONOCLONAL ANTIBODY; PRION PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DNA DENATURATION; IMMUNIZATION; MOLECULAR DYNAMICS; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCRAPIE; SURFACE PROPERTY;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY AFFINITY; EPITOPE MAPPING; EPITOPES; GUANIDINE; IMMUNIZATION; MICE; MICE, KNOCKOUT; MUTATION; PHOSPHATIDYLCHOLINES; PROTEIN CONFORMATION; PROTEIN DENATURATION; PROTEIN ISOFORMS; PRPC PROTEINS; PRPSC PROTEINS; RECOMBINANT PROTEINS;

EID: 1542270865     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2003.10.026     Document Type: Article

References (37)

1. Barry R.A., Prusiner S.B. Monoclonal antibodies to the cellular and scrapie prion proteins. J. Infect. Dis. 154:1986;518-521.
2. Bolton D.C., Bendheim P.E., Marmorstein A.D., Potempska A. Isolation and structural studies of the intact scrapie agent protein. Arch. Biochem. Biophys. 258:1987;579-590.
3. Caughey B.W., Dong A., Bhat K.S., Ernst D., Hayes S.F., Caughey W.S. Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. Biochemistry. 30:1991;7672-7680.
4. Caughey B., Kocisko D.A., Raymond G.J., Lansbury P.T. Jr. Aggregates of scrapie-associated prion protein induce the cell-free conversion of protease-sensitive prion protein to the protease-resistant state. Chem. Biol. 2:1995;807-817.
5. Caughey B., Raymond G.J., Kocisko D.A., Lansbury P.T. Jr. Scrapie infectivity correlates with converting activity, protease resistance, and aggregation of scrapie-associated prion protein in guanidine denaturation studies. J. Virol. 71:1997;4107-4110.
6. Gabizon R., McKinley M.P., Prusiner S.B. Purified prion proteins and scrapie infectivity copartition into liposomes. Proc. Natl. Acad. Sci. U.S.A. 84:1987;4017-4021.
7. Gasset M., Baldwin M.A., Lloyd D.H., Gabriel J.M., Holtzman D.M., Cohen F., Fletterick R., Prusiner S.B. Predicted alpha-helical regions of the prion protein when synthesized as peptides form amyloid. Proc. Natl. Acad. Sci. U.S.A. 89:1992;10940-10944.
8. Grathwohl K.U., Horiuchi M., Ishiguro N., Shinagawa M. Sensitive enzyme-linked immunosorbent assay for detection of PrP(Sc) in crude tissue extracts from scrapie-affected mice. J. Virol. Methods. 64:1997;205-216.
9. Harmeyer S., Pfaff E., Groschup M.H. Synthetic peptide vaccines yield monoclonal antibodies to cellular and pathological prion proteins of ruminants. J. Gen. Virol. 79:1998;937-945.
10. Holscher C., Delius H., Burkle A. Overexpression of nonconvertible PrPc delta114-121 in scrapie-infected mouse neuroblastoma cells leads to trans-dominant inhibition of wild-type PrP(Sc) accumulation. J. Virol. 72:1998;1153-1159.
11. Hope J., Morton L.J., Farquhar C.F., Multhaup G., Beyreuther K., Kimberlin R.H. The major polypeptide of scrapie-associated fibrils (SAF) has the same size, charge distribution and N-terminal protein sequence as predicted for the normal brain protein (PrP). EMBO J. 5:1986;2591-2597.
12. Horiuchi M., Yamazaki N., Ikeda T., Ishiguro N., Shinagawa M. A cellular form of prion protein (PrPC) exists in many non-neuronal tissues of sheep. J. Gen. Virol. 76:1995;2583-2587.
13. Kaneko K., Zulianello L., Scott M., Cooper C.M., Wallace A.C., James T.L., Cohen F.E., Prusiner S.B. Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. Proc. Natl. Acad. Sci. U.S.A. 94:1997;10069-10074.
14. Kanyo Z.F., Pan K.M., Williamson R.A., Burton D.R., Prusiner S.B., Fletterick R.J., Cohen F.E. Antibody binding defines a structure for an epitope that participates in the PrPC→PrPSc conformational change. J. Mol. Biol. 293:1999;855-863.
15. Kascsak R.J., Rubenstein R., Merz P.A., Tonna-DeMasi M., Fersko R., Carp R.I., Wisniewski H.M., Diringer H. Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J. Virol. 61:1987;3688-3693.
16. Korth C., Stierli B., Streit P., Moser M., Schaller O., Fischer R., Schulz-Schaeffer W., Kretzschmar H., Raeber A., Braun U., Ehrensperger F., Hornemann S., Glockshuber R., Riek R., Billeter M., Wuthrich K., Oesch B. Prion (PrPSc)-specific epitope defined by a monoclonal antibody. Nature. 390:1997;74-77.
17. Krasemann S., Groschup M.H., Harmeyer S., Hunsmann G., Bodemer W. Generation of monoclonal antibodies against human prion proteins in PrP0/0 mice. Mol. Med. 2:1996;725-734.
18. Meyer R.K., McKinley M.P., Bowman K.A., Braunfeld M.B., Barry R.A., Prusiner S.B. Separation and properties of cellular and scrapie prion proteins. Proc. Natl. Acad. Sci. U.S.A. 83:1986;2310-2314.
19. Muramoto T., Scott M., Cohen F.E., Prusiner S.B. Recombinant scrapie-like prion protein of 106 amino acids is soluble. Proc. Natl. Acad. Sci. U.S.A. 93:1996;15457-15462.
20. O'Rourke K.I., Baszler T.V., Miller J.M., Spraker T.R., Sadler-Riggleman I., Knowles D.P. Monoclonal antibody F89/160.1.5 defines a conserved epitope on the ruminant prion protein. J. Clin. Microbiol. 36:1998;1750-1755.
21. Pan K.M., Baldwin M., Nguyen J., Gasset M., Serban A., Groth D., Mehlhorn I., Huang Z., Fletterick R.J., Cohen F.E. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc. Natl. Acad. Sci. U.S.A. 90:1993;10962-10966.
22. Paramithiotis E., Pinard M., Lawton T., LaBoissiere S., Leathers V.L., Zou W.Q., Estey L.A., Lamontagne J., Lehto M.T., Kondejewski L.H., Francoeur G.P., Papadopoulos M., Haghighat A., Spatz S.J., Head M., Will R., Ironside J., O'Rourke K., Tonelli Q., Ledebur H.C., Chakrabartty A., Cashman N.R. A prion protein epitope selective for the pathologically misfolded conformation. Nat. Med. 9:2003;893-899.
23. Peretz D., Williamson R.A., Matsunaga Y., Serban H., Pinilla C., Bastidas R.B., Rozenshteyn R., James T.L., Houghten R.A., Cohen F.E., Prusiner S.B., Burton D.R. A conformational transition at the N terminus of the prion protein features in formation of the scrapie isoform. J. Mol. Biol. 273:1997;614-622.
24. Prusiner S.B. Molecular biology of prion diseases. Science. 252:1991;1515-1522.
25. Prusiner S.B., Groth D., Serban A., Stahl N., Gabizon R. Attempts to restore scrapie prion infectivity after exposure to protein denaturants. Proc. Natl. Acad. Sci. U.S.A. 90:1993;2793-2797.
26. Riek R., Hornemann S., Wider G., Billeter M., Glockshuber R., Wuthrich K. NMR structure of the mouse prion protein domain PrP(121-321). Nature. 382:1996;180-182.
27. Safar J., Roller P.P., Gajdusek D.C., Gibbs C.J. Jr. Conformational transitions, dissociation, and unfolding of scrapie amyloid (prion) protein. J. Biol. Chem. 268:1993;20276-20284.
28. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Press, Cold Spring Harbor, NY.
29. Serban D., Taraboulos A., DeArmond S.J., Prusiner S.B. Rapid detection of Creutzfeldt-Jakob disease and scrapie prion proteins. Neurology. 40:1990;110-117.
30. Shinagawa M., Takahashi K., Sasaki S., Doi S., Goto H., Sato G. Characterization of scrapie agent isolated from sheep in Japan. Microbiol. Immunol. 29:1985;543-551.
31. Wille H., Michelitsch M.D., Guenebaut V., Supattapone S., Serban A., Cohen F.E., Agard D.A., Prusiner S.B. Structural studies of the scrapie prion protein by electron crystallography. Proc. Natl. Acad. Sci. U.S.A. 99:2002;3563-3568.
32. Williamson R.A., Peretz D., Smorodinsky N., Bastidas R., Serban H., Mehlhorn I., DeArmond S.J., Prusiner S.B., Burton D.R. Circumventing tolerance to generate autologous monoclonal antibodies to the prion protein. Proc. Natl. Acad. Sci. U.S.A. 93:1996;7279-7282.
33. Williamson R.A., Peretz D., Pinilla C., Ball H., Bastidas R.B., Rozenshteyn R., Houghten R.A., Prusiner S.B., Burton D.R. Mapping the prion protein using recombinant antibodies. J. Virol. 72:1998;9413-9418.
34. Wopfner F., Weidenhofer G., Schneider R., von Brunn A., Gilch S., Schwarz T.F., Werner T., Schatzl H.M. Analysis of 27 mammalian and 9 avian PrPs reveals high conservation of flexible regions of the prion protein. J. Mol. Biol. 289:1999;1163-1178.
35. Yokoyama T., Kimura K.M., Ushiki Y., Yamada S., Morooka A., Nakashiba T., Sassa T., Itohara S. In vivo conversion of cellular prion protein to pathogenic isoforms, as monitored by conformation-specific antibodies. J. Biol. Chem. 276:2001;11265-11271.
36. Zanusso G., Liu D., Ferrari S., Hegyi I., Yin X., Aguzzi A., Hornemann S., Liemann S., Glockshuber R., Manson J.C., Brown P., Petersen R.B., Gambetti P., Sy M.S. Prion protein expression in different species: analysis with a panel of new mAbs. Proc. Natl. Acad. Sci. U.S.A. 95:1998;8812-8816.
37. Zhang H., Kaneko K., Nguyen J.T., Livshits T.L., Baldwin M.A., Cohen F.E., James T.L., Prusiner S.B. Conformational transitions in peptides containing two putative alpha-helices of the prion protein. J. Mol. Biol. 250:1995;514-526.